AI Verdict
NEPH has stronger fundamentals based on our AI analysis.
NEPH vs NEO Fundamental Comparison
| Metric | NEPH | NEO |
|---|---|---|
| Revenue | $18.8M | $727.3M |
| Net Income | $1.2M | $-108.0M |
| Net Margin | 6.4% | -14.9% |
| ROE | 11.7% | -12.9% |
| ROA | 8.8% | -7.9% |
| Current Ratio | 4.06x | 4.26x |
| Debt/Equity | 0.01x | 0.41x |
| EPS | $0.11 | $-0.21 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
NEPH vs NEO: Frequently Asked Questions
Is NEPH or NEO a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), NEPH has stronger fundamentals. NEPH is rated BUY (75% confidence) while NEO is rated SELL (78% confidence). This is not investment advice.
How does NEPH compare to NEO fundamentally?
NEPHROS INC has ROE of 11.7% vs NEOGENOMICS INC's -12.9%. Net margins are 6.4% vs -14.9% respectively.
Which stock pays higher dividends, NEPH or NEO?
NEPH has a dividend yield of N/A or no dividend while NEO has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in NEPH or NEO for long term?
For long-term investing, consider that NEPH has BUY rating with 75% confidence, while NEO has SELL rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about NEPH vs NEO?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For NEPH vs NEO, the AI consensus favors NEPH based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.